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Laryngopharyngealreﬂux(LPR)ispartoftheso-calledextraesophagealmanifestationsofgastroesophagealreﬂuxdisease(GERD).
It is presented by unspeciﬁc symptoms and signs and is believed to be caused by the reﬂux of gastric content to the proximal
esophagus and larynx. However, evidence considering the role of the antireﬂux surgery for LPR has failed to demonstrate results
comparable to those for GERD. The aim of this paper is to review the current literature regarding the impact of laparoscopic
fundoplication for the treatment of LPR.
1.Introduction
Gastroesophageal reﬂux disease (GERD) is deﬁned as a
condition that develops when the reﬂux of stomach contents
into the esophagus causes troublesome symptoms and/or
complications and represents the failure of the antireﬂux
barrier[1]. It has long been recognized as a signiﬁcant public
health concern, since heartburn aﬄicts nearly two-thirds of
US adults at some point in their lives and accounts for a
great number of physician oﬃce visits every year [2]. While
most GERD patients suﬀer from typical esophageal manifes-
tations, such as heartburn and regurgitation, there is a subset
ofpatientswhoexperiencetheso-calledlaryngealsymptoms,
which may be caused by laryngopharyngeal reﬂux (LPR)
[3]. Table 1 displays the most frequent symptoms associated
with LPR, which are unspeciﬁc and can be found in other
otolaryngologic disorders [4].
Despite the advances in medical management for GERD,
the surgical treatment has been studied more methodically
since the introduction of laparoscopic Nissen fundoplication
[5], and increasing numbers of patients have opted for
the surgical treatment since the advent of this minimally
invasive technique. However, most of the studies regarding
the surgical treatment for LPR symptoms have failed to
show results as good as those for GERD symptoms [6].
Interestingly,theeﬃcacyofmedicaltreatmentforLPRisalso
not comparable to that for GERD [7].
Although LPR and GERD have diﬀerent clinical pre-
sentation and response to management, accumulating evi-
dence shows the correlation between the pathophysiology
of both entities, which is the reﬂux of the gastric content
to esophagus or proximally, to the larynx [8]. Perry et
al. 2008 [9] showed that, in the upright position, LPR
patients have the same degree of gastric cardia dilation
that is found in patients with typical GERD symptoms and
those with a mixed presentation, suggesting that the same
pathophysiologic disturbance that predisposes typical GERD
patients to reﬂux is present in patients with symptoms of
LPR. Furthermore, acid reﬂux is thought to lead to not only2 International Journal of Otolaryngology










laryngeal alterations associated with LPR, but also the direct
contact of the laryngeal epithelium with gastric reﬂuxate
containing pepsin, bile acids, and other components, which
are not prevented by the proton pump inhibitors (PPIs) [8].
Taking together, this evidence suggests that the antireﬂux
surgery should have good results in LPR patients as well,
since it provides an eﬀective barrier to gastroesophageal
reﬂux and eliminates both acid and nonacid reﬂux.
The aim of this paper is to present the current evidence
regarding the impact of laparoscopic fundoplication (LF) for
the treatment of LPR.
2.MaterialsandMethods
A Medline, PubMed, and Cochrane database search was
done to ﬁnd articles in the English language on surgery
for LPR in adults. The following keywords were used:
“surgery/fundoplication and extraesophageal manifestations
of gastroesophageal reﬂux,” “surgery/fundoplication and
laryngopharyngeal reﬂux,” and “surgery/fundoplication and
atypical symptoms of gastroesophageal reﬂux.” Related
articles and links were searched. Additional articles were
identiﬁed by a manual search of the references from the key
articles. only articles regarding antireﬂux surgery speciﬁcally
for the treatment of LPR and not including lower respiratory
or other extraesophageal symptoms of GERD were selected.
3. Results
At o t a lo fﬁ v es t u d i e sw e r es e l e c t e d .T h e r ew e r en or a n -
domized clinical trials and only one study had a control
group. The inclusion criteria, preoperative evaluation, and
endpoints are not standardized, making the data too hetero-
geneous.
Westcott et al. 2004 [10] studied 41 patients submitted to
LF due to LPR symptoms. After a mean follow-up time of 14
months, he observed 84% improvement in reﬂux symptom
index (RSI). From the preoperative evaluation, the factors
signiﬁcantly associated with poor outcome after surgery
werestructuralchangesseeninlaryngoscopy(i.e.,vocal-cord
scarring, paresis, granuloma, and carcinoma or subglottic
stenosis) and no improvement with PPIs treatment.
Swoger et al. 2006 [11]c o n d u c t e dac o n t r o l l e ds t u d y
with 25 patients presenting LPR symptoms that did not
respond to aggressive PPI treatment (omeprazole 40mg
twice daily or lansoprazole 60mg twice daily for 4 months).
From this group, patients who decided to submit to LF
(n = 10) were compared to the ones who decided to
keep on medical management (control group n = 15).
No signiﬁcant improvement in symptom scale was observed
in both groups, despite a signiﬁcant improvement in pH
and laryngoscopy scores after surgery. Some patients have
demonstrated improvement in symptoms by treating addi-
tional pathologies such as allergy or asthma.
Catania et al. 2007 [12] studied 58 patients submitted to
LF for laryngopharyngeal reﬂux, for a mean followup of 15.4
months. Since the ﬁrst month after surgery, he observed 97%
improvement in symptoms (decrease >5 points in RIS) and
65% of total response (patients experiencing no symptoms).
These results were maintained on late follow-up evaluation.
Also, there was a signiﬁcant increase in quality-of- life index
used measured by laryngopharyngeal reﬂux-health-related
quality-of-life index.
Sala et al. 2008 [13] evaluated vocal and laryngeal
symptoms in 22 patients submitted to LF for LPR, after a
3 months course of medical treatment. Vocal and laryngeal
symptoms signiﬁcantly improved after 3 months of medical
treatment and kept improving after surgery, showing a sta-
tistically signiﬁcant diﬀerence between pre-and postsurgical
treatment too. However, voice quality and laryngeal ﬁndings
only showed a signiﬁcant improvement after surgery.
Wassenaar et al. 2011 [14] introduced a new approach
to preoperative evaluation. While most of the studies
use classical evaluation with dual-probe 24h-esophageal
pHmetry, upper endoscopy, laryngoscopy, in this study,
patients were additionally evaluated with laryngeal pepsin
measured by western blotting in sputum and posterior
laryngeal biopsies. All but one patient with LPR symptoms
were positive for pepsin in laryngeal biopsy before surgery.
Also, sputum was collected preoperatively in 5 patients
and 4 of these were positive for pepsin, in correlation
with correspondent biopsy. Seven patients were submitted
to LF, and 2 were submitted to endoscopic fundoplication
(EsophyX, EndoGastric Solutions, Redmond, Wash). From
these 2 patients, 1 had to be submitted to LF for failure
of the endoscopic treatment. Eight patients had symptom
improvement (6 good improvement and 2 mild), and 1
had no improvement. From the 8 patients who experienced
improvement, 7 were negative for pepsin in postoperative
sputum analyses, and 1 had a consistent decrease in pepsin
(from +++ preoperatively to + after surgery). The only one
patient who did not experience improvement was negative
for pepsin in preoperative biopsies and sputum.
4. Discussion
Literature review demonstrated additional studies regarding
surgical treatment for LPR, but including patients with
other extraesophageal symptoms, such as lower respiratory
symptoms [15, 16]. We decided to exclude those studies
from this paper in order to achieve a more speciﬁc analysis,
since even the studies directed to LPR present critically
heterogeneous evidence. Whereas most studies had shown
some degree of symptomatic improvement after surgicalInternational Journal of Otolaryngology 3
fundoplication, further conclusions are challenging, due to
the weak evidence grade of the studies.
A possible explanation to the diﬃculty of the studies in
provingthe eﬃcacyof LFforLPRis that,inmost of thestud-
ies,thediagnosisofLPRisfocusedontraditionalmeasuresof
gastroesophageal reﬂux (esophagoscopy or pH monitoring),
identiﬁcation of injury by laryngoscopy, pharyngeal pH
monitoring, or empiric treatment of symptoms by PPIs,
which have demonstrated not to be reliable diagnostic tools
[6]. LPR presents with a spectrum of symptoms and signs
that are very unspeciﬁc and most of the times not associated
t oc l a s s i c a lG E R Ds y m p t o m s[ 17]. Therefore, any advance in
preoperative evaluation that could lead to a more speciﬁc
characterization of the LPR and the correlation of the
symptoms with the gastric reﬂux will help to study the eﬀect
of the restoration of the antireﬂux barrier in those patients.
Recent studies have focused on more speciﬁc methods
for diagnosis and prediction of response to treatment in
LPR patients [18]. Although not controlled and with a small
number of patients, the study by Wassenaar et al. 2011 [14]
probably brought a more speciﬁc marker for LPR, with
a good correlation between symptoms and reﬂux, which
marked even the eﬃcacy of LF. Pepsin in sputum and/or in
laryngeal biopsies must now be studied in large randomized
controlled trials.
Another important factor to be taken into account
is the body mass index (BMI) of subjects submitted to
surgery. From the studies presented above, only one has
provided the BMI of the patients [14]. Several studies have
proposed a causative role for obesity on GERD [19, 20],
but the correlation between obesity and LPR is still poorly
understood [21, 22]. Additionally, long-term control of
GERD by LF in obese patients seems to be worse than in
normal weight subjects [23]. Therefore, patients BMI must
bewellcharacterizedinanystudyregardingtheeﬃcacyofLF.
5. Conclusion
Results of LF for the treatment of GERD are well established
[24], and, in theory, both GERD and LPR share a simi-
lar pathophysiology. Consequently, well-indicated antireﬂux
surgery should be as eﬀective for LPR as for GERD. Many
studies have demonstrated symptomatic improvement after
surgical fundoplication. However, the current knowledge
presented by the literature does not allow this conclusion.
Large multicenter, randomized control trials are needed,
focusing on diagnostic tools to improve selection criteria,
presenting standard end-points and long-term followup.
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